Be the first to receive investor updates.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce tortor nulla, efficitur at magna sed, gravida venenatis lectus. Sed viverra est ac lectus viverra, condimentum efficitur metus condimentum.

Success! Your contact information has been successfully added to Clearmind Medicine's list.

Oops! Something went wrong while subscribing. Please try again.

Support Life-Changing Treatments

Invest in Clearmind and help develop new medicines, designed to help people who suffer from mental health issues and binge behaviours.

Investor resources

Company Highlights

A Mature IP Portfolio, Innovative R&D, and Solid Financial Backbone

Why We’re Different

We develop our proprietary treatments to be self-administered and show immediate results.

The information presented in this table is based solely on the Company’s own market research. Actual information may contradict the Company’s findings.

The Opportunity

The market of alcohol-related psychedelic treatments has low competitive density.


of clinical trials are

There are only 21 Alcohol related clinical trials,

... out of a total of 1302 registered clinical trials of psychedelics.

This information is based on the clinical studies available on

Investor Information

Learn more about Clearmind’s unique approach and strategy.

SEC Filings
SEDAR Filings
Corporate Presentation


Access Clearmind's corporate information.

Board of directors
Board Diversity Matrix
Articles of association
Code of conduct and ethics
Audit committee charter
Compensation committee charter
Nominating and corporate governance committee charter
View Board of Directors

News Releases

View All

Investor Frequently Asked Questions

How can I invest in Clearmind?

What is Clearmind’s fiscal year?

How does Clearmind prepare their financial statements?

Does Clearmind pay any dividends?

When will the next financials be released?

Join Us

Let's Make History


Reason for Inquiry

Thank you for sending your contact information—your details have been received.

Oops! Something went wrong. Please try again.